{"doi":"10.1093/rheumatology/kew427","title":"Pathways leading to an immunological disease: systemic lupus erythematosus","abstract":null,"journal":"Rheumatology","year":2017,"id":17964,"datarank":6.434862177766206,"base_score":5.170483995038151,"endowment":5.170483995038151,"self_citation_contribution":0.7755725992557229,"citation_network_contribution":5.659289578510483,"self_endowment_contribution":0.7755725992557229,"citer_contribution":5.659289578510483,"corpus_percentile":null,"corpus_rank":null,"citation_count":175,"citer_count":165,"citers_with_citation_signal":139,"citers_with_endowment":139,"datacite_reuse_total":10,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":126592,"name":"Teja Celhar","orcid":null,"position":1,"is_corresponding":false},{"id":126593,"name":"Petra D. Cravens","orcid":null,"position":2,"is_corresponding":false},{"id":126594,"name":"Anne B. Satterthwaite","orcid":null,"position":3,"is_corresponding":false},{"id":126595,"name":"Anna-Marie Fairhurst","orcid":null,"position":4,"is_corresponding":false},{"id":126596,"name":"Laurie S. Davis","orcid":null,"position":5,"is_corresponding":false},{"id":126591,"name":"Olga Zharkova","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.170483995038151,"endowment":5.170483995038151,"datacite_reuse_total":10,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"28375453","pmcid":"PMC5410978","openalex_id":"https://openalex.org/W2602880968","authors":[],"funders":[{"funder_name":"NIAID NIH HHS","grant_id":"R01 AI122720","title":null},{"funder_name":"NIAMS NIH HHS","grant_id":"R21 AR067625","title":null},{"funder_name":"National Institutes of Health","grant_id":"5R21AR067625-02","title":"Attenuation of Lupus by Foxo3"},{"funder_name":"National Institutes of Health","grant_id":"1R01AI122720-01A1","title":"Regulation and Consequences of Ets1 Downregulation in B Cells"}],"total_grants":4,"fwci":15.1492,"citation_percentile":0.99435469,"influential_citations":6,"citation_trend":[{"year":2017,"count":3},{"year":2018,"count":17},{"year":2019,"count":28},{"year":2020,"count":22},{"year":2021,"count":26},{"year":2022,"count":22},{"year":2023,"count":14},{"year":2024,"count":24},{"year":2025,"count":15},{"year":2026,"count":4}],"oa_status":"bronze","license":"CC BY NC","oa_locations":[{"url":"https://academic.oup.com/rheumatology/article-pdf/56/suppl_1/i55/11113272/kew427.pdf","host_type":"journal"},{"url":"https://academic.oup.com/rheumatology/article-pdf/56/suppl_1/i55/11113272/kew427.pdf","host_type":"HYBRID"},{"url":"https://academic.oup.com/rheumatology/article-pdf/56/suppl_1/i55/11113272/kew427.pdf","host_type":"publisher"},{"url":"http://academic.oup.com/rheumatology/article-pdf/56/suppl_1/i55/11113272/kew427.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1093/rheumatology/kew427","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/28375453","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5410978","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC5410978","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC5410978?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.1093/rheumatology/kew427","host_type":""},{"url":"https://dx.doi.org/10.1093/rheumatology/kew427","host_type":""}],"fields_of_study":["Systemic Lupus Erythematosus Research","T-cell and B-cell Immunology","Immune Cell Function and Interaction","Medicine","Biology","0301 basic medicine","03 medical and health sciences","0302 clinical medicine","Autoimmunity","B-Lymphocytes","Cytokines","Environment","Genetic Predisposition to Disease","Humans","Inflammation","Lupus Erythematosus, Systemic","Self Tolerance"],"mesh_terms":["B-Lymphocytes","Environment","Humans","Inflammation","Lupus Erythematosus, Systemic","Autoimmunity","Cytokines","Self Tolerance","Genetic Predisposition to Disease"],"keywords":["Immunology","Autoimmunity","Medicine","Disease","Immune system","Autoimmune disease","Chemokine","Immune dysregulation","Inflammation","Antibody","Pathology","Autoantibodies","Tolerance","SLE","systemic lupus erythematosus","Tissue Destruction","Sle Pathogenesis","B-Lymphocytes","Reviews","Environment","Self Tolerance","Cytokines","Humans","Lupus Erythematosus, Systemic","Genetic Predisposition to Disease"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.12552365.v1","title":"Additional file 1 of An integrative Bayesian network approach to highlight key drivers in systemic lupus erythematosus","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12552365","title":"Additional file 1 of An integrative Bayesian network approach to highlight key drivers in systemic lupus erythematosus","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24892850.v1","title":"Additional file 1 of Prevalence of oral mucosal lesions in patients with systemic Lupus Erythematosus: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24892850","title":"Additional file 1 of Prevalence of oral mucosal lesions in patients with systemic Lupus Erythematosus: a systematic review and meta-analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25670220.v1","title":"Additional file 1 of T cell expressions of aberrant gene signatures and Co-inhibitory receptors (Co-IRs) as predictors of renal damage and lupus disease activity","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25670220","title":"Additional file 1 of T cell expressions of aberrant gene signatures and Co-inhibitory receptors (Co-IRs) as predictors of renal damage and lupus disease activity","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25801006.v1","title":"Additional file 1 of Efficacy and safety study of targeted small-molecule drugs in the treatment of systemic lupus erythematosus","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25801006","title":"Additional file 1 of Efficacy and safety study of targeted small-molecule drugs in the treatment of systemic lupus erythematosus","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25801093.v1","title":"Additional file 2 of Efficacy and safety study of targeted small-molecule drugs in the treatment of systemic lupus erythematosus","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25801093","title":"Additional file 2 of Efficacy and safety study of targeted small-molecule drugs in the treatment of systemic lupus erythematosus","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-03T02:58:18.139338Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}